Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Nashville’s Top Eye Surgeon, Dr. Stewart Shofner Successfully Treats Glaucoma Patients Using a Procedure Known as Selective Laser Trabeculoplasty (SLT)
  • USA - English


News provided by

Shofner Vision Center

Jul 31, 2014, 21:50 ET

Share this article

Share toX

Share this article

Share toX

If the drainage angle is blocked, excess fluid cannot flow out of the eye, causing the fluid pressure to increase.
If the drainage angle is blocked, excess fluid cannot flow out of the eye, causing the fluid pressure to increase.

Early detection is key in preventing permanent vision loss.

Post this

Nashville, TN (PRWEB) July 31, 2014 -- Dr. Stewart Shofner of Shofner Vision Center in Nashville, TN was one of the first surgeons in the United States to successfully treat glaucoma by performing eye surgery using the iStent, the smallest medical device ever approved by the FDA. Dr. Shofner is also one of the first surgeons to recognize the benefits of using a procedure known as Selective Laser Trabeculoplasty (SLT) to successfully treat patients with glaucoma. Dr. Shofner and his colleagues now recognize that this procedure is a primary treatment for many patients who find it difficult and expensive to administer eye drops routinely.

About Glaucoma
Glaucoma is a condition where the eye’s natural drainage system becomes clogged and pressure builds up dangerously in the eye. It is a complicated disease in which damage to the optic nerve leads to progressive, irreversible vision loss. According to the World Health Organization, glaucoma is the second leading cause of blindness. Prevent Blindness America reported it is estimated that over 2.2 million Americans have glaucoma but only half of those know they have it. "A comprehensive eye exam and detecting glaucoma early is key in preventing permanent vision loss," say Dr. Shofner.

Glaucoma Treatment Options
Different treatment options may be considered depending on the type of glaucoma. Topical eye medications (eye drops) or oral medications (pills) can be very effective at controlling intraocular pressure to prevent eye damage for many patients. However, some patients may require surgery to reduce their intraocular pressure to a safe level by improving the outflow or drainage of fluids. After surgery, a patient’s dependency on expensive eye drops to control glaucoma is either reduced significantly or even eliminated. Others may need to continue using eye drops post glaucoma surgery.

The SLT Procedure
The selective laser trabeculoplasty (SLT) procedure increases outflow of internal eye fluid. The laser, performed by an ophthalmologist, is used to create tiny holes in the filtration angle of the eye, where the cornea and iris meet. The SLT creates minimal heat damage to adjacent tissue, which generally means the procedure can be repeated safely. Recent studies indicate and Dr. Shofner agrees that this laser procedure may be equally as effective as glaucoma eye drops for lowering internal eye pressure.

Shunts and Stents
Other options for glaucoma treatments include shunts and stents, which are small devices that are surgically inserted into the eye during a trabeculectomy to increase outflow of intraocular fluid and reduce high eye pressure. The iStent Trabecular Micro-Bypass (iStent) is made of surgical-grade titanium and is safely implanted in the internal eye area to re-establish a normal flow of fluids within the eye. Stents used in the medical industry are tubes inserted into the human body to improve blood flow or provide easy access for medications or even surgery. The iStent creates a new opening, which eliminates any blockage that hinders the eye’s natural fluid outflow. As with the SLT procedure, the iStent may be a permanent way to reduce or even eliminate a glaucoma patient’s reliance on medication.

Glaucoma treatments (laser and non-laser) are designed to decrease the production of intraocular fluid or increase the outflow (drainage) of this same fluid. Treatment is necessary to reduce or stabilize one’s intraocular pressure in order to prevent optic nerve damage.

Prevention
Routine eye exams to determine early diagnosis are the best way to prevent vision loss from glaucoma. People that are high risk for developing glaucoma due to elevated intraocular pressure, family history, ethnic background, age or optic nerve appearance should consult with a qualified eye doctor or ophthalmologist to determine the frequency of their eye exams.

About Shofner Vision Center
Dr. Stewart Shofner of Shofner Vision Center located in the heart of downtown Nashville, TN, specializes in affordable LASIK and cataract vision correction surgery and treats ocular diseases. Dr. Shofner has performed over 10,000 cataract surgeries and over 30,000 LASIK/PRK surgeries in Nashville/Middle Tennessee area. Dr. Shofner recommends anyone experiencing glaucoma symptoms or vision impairment should contact their local ophthalmologist or contact Shofner Vision Center for a "No Fear - No Pressure" exam to determine which vision correction procedure is most appropriate.

Dr. Stewart Shofner, Shofner Vision Center, http://www.shofnervisioncenter.com, +1 (615) 340-4733, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.